An increased accessibility of Il21 promoter is observed in CKO CD4+ T cells, and severity of Blimp-1 deficiency–mediated colitis can be restored by histone acetyltransferase CBP/p300 inhibitor. The gene discussed is CD4; the disease is colitis.